首页> 美国卫生研究院文献>Human Vaccines Immunotherapeutics >Oral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum suggesting that PorA behaves as a putative adjuvant
【2h】

Oral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum suggesting that PorA behaves as a putative adjuvant

机译:与幽门螺杆菌HpaA抗原基因融合的重组脑膜炎奈瑟氏球菌PorA的口服给药可提高小鼠血清中的抗体水平这表明PorA可作为辅助佐剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Neisseria meningitidis outer membrane protein PorA from a Chilean strain was purified as a recombinant protein. PorA mixed with AbISCO induced bactericidal antibodies against N. meningitidis in mice. When PorA was fused to the Helicobacter pylori HpaA antigen gene, the specific response against H. pylori protein increased. Splenocytes from PorA-immunized mice were stimulated with PorA, and an increase in the secretion of IL-4 was observed compared with that of IFN-γ. Moreover, in an immunoglobulin sub-typing analysis, a substantially higher IgG1 level was found compared with IgG2a levels, suggesting a Th2-type immune response. This study revealed a peculiar behavior of the purified recombinant PorA protein per se in the absence of AbISCO as an adjuvant. Therefore, the resistance of PorA to proteolytic enzymes, such as those in the gastrointestinal tract, was analyzed, because this is an important feature for an oral protein adjuvant. Finally, we found that PorA fused to the H. pylori HpaA antigen, when expressed in Lactococcus lactis and administered orally, could enhance the antibody response against the HpaA antigen approximately 3 fold. These observations strongly suggest that PorA behaves as an effective oral adjuvant.
机译:来自智利菌株的脑膜炎奈瑟氏球菌外膜蛋白PorA被纯化为重组蛋白。 PorA与AbISCO混合,可诱导小鼠抗脑膜炎奈瑟氏菌的杀菌抗体。当PorA与幽门螺杆菌HpaA抗原基因融合时,针对幽门螺杆菌蛋白的特异性反应增加。用PorA刺激来自PorA免疫小鼠的脾细胞,与IFN-γ相比,IL-4的分泌增加。此外,在免疫球蛋白亚型分析中,发现IgG1水平明显高于IgG2a水平,这表明Th2型免疫应答。这项研究揭示了在没有AbISCO作为佐剂的情况下,纯化的重组PorA蛋白本身的独特行为。因此,分析了PorA对蛋白水解酶(如胃肠道中的酶)的抗性,因为这是口服蛋白质佐剂的重要特征。最后,我们发现与乳酸杆菌HpaA抗原融合的PorA在乳酸乳球菌中表达并口服后,可增强针对HpaA抗原的抗体应答约3倍。这些观察结果强烈表明,PorA可作为有效的口服佐剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号